YU94592A - Kompleksne soli hematoporfirina i njegovih derivata i postupak za njihovo dobivanje - Google Patents

Kompleksne soli hematoporfirina i njegovih derivata i postupak za njihovo dobivanje

Info

Publication number
YU94592A
YU94592A YU94592A YU94592A YU94592A YU 94592 A YU94592 A YU 94592A YU 94592 A YU94592 A YU 94592A YU 94592 A YU94592 A YU 94592A YU 94592 A YU94592 A YU 94592A
Authority
YU
Yugoslavia
Prior art keywords
carboxy
ethylamino
propylamino
butylamino
hydroxy
Prior art date
Application number
YU94592A
Other languages
English (en)
Other versions
YU48961B (sh
Inventor
A. Graczyk
J. Konarski
Original Assignee
Wojskowa Akademia Techniczna Im.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wojskowa Akademia Techniczna Im. filed Critical Wojskowa Akademia Techniczna Im.
Priority to HRP-945A priority Critical patent/HRP921337B1/xx
Publication of YU94592A publication Critical patent/YU94592A/sh
Publication of YU48961B publication Critical patent/YU48961B/sh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0036Porphyrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/005Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052Small organic molecules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

nove kompleksne soli hematoporfirina i njegovih derivata imaju formulu 1, u kojoj R1 i R2 su identični ili različiti i označavaju -CN=CH2, -CH(OH)-CH3 ili CH(OH)-CH3 grupe, gde R3 predstavlja grupu koja gradi oligomer koji sadrži etraske i/ili estarske veze, ova grupa obuhvata od 1 do 5 identičnih ili različitih jedinica izvedenih iz monomera formule 2 ili R1 i R2 su identični i označavaju CH(R4)-CH3 grupu, gde R4 predstavlja grupe: karboksimetilamino, 1-karbok-sipentilamino, 1-karboksi-2-metilpropilamino, 1-karboksi-3-metil-butilamino, 1-karboksi-2-metil-butilamino, 1-karboksi-butilamino, 1-karboksipentilamino, 1-karboksi-2-hidroksietilamino, 1-karboksi-2-hidroksi-propilamino, 1-karboksi-2-merkapto-etilamino, 1-karboksi-3-metiltio-propilamino, 1,2-dikarboksi-etilamino, 1-karboksi-2-kar-bamoil-etilamino, 1,3-dikarboksi-propilamino, 1-karboksi-3-kar-bamoil-propilamino, 1-karboksi-2-fenil-etilamino, 1-karboksi-2-(4-hidroksifenil)-etilamino, 1-karboksi-2-indolil-etilamino, 2-karboksi-pirolidinil, 2-karboksi-4-hidroksi-pirolidinil, 1-karboksi-5-amino-pentilamino, 1-karboksi-4-guanidil-butilamino, 1-karboksi-4-hidrok-si-5-amino-pentilamino ili 1-karboksi-2-(1H-imidazol)etilamino grupu, A označava baznu amino kiselinu, m je 2-6 i n je 1-5. Postupak za dobivanje novih kompleksnih soli formule L sastoji se u reagovanju sa baznom amino kiselinom hematoporfirin derivata opšte formule 4, u kojoj R1 i R2 imaju napred data značenja. Nove kompleksne soli se koriste kao terapeutsko sredstvo za detek-ciju i tretiranje neoplazmi.
YU94592A 1991-10-29 1992-10-29 Kompleksne soli hematoporfirina i njegovih derivata i njihova sinteza YU48961B (sh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HRP-945A HRP921337B1 (en) 1991-10-29 1992-11-24 Complex salts of hematoporphyrin and of its derivatives, their synthesis and therapeutic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL91292220A PL165249B1 (pl) 1991-10-29 1991-10-29 Sposób otrzymywania soli kompleksowych hematoporfiryny i jej pochodnych PL PL PL PL PL PL PL

Publications (2)

Publication Number Publication Date
YU94592A true YU94592A (sh) 1995-12-04
YU48961B YU48961B (sh) 2003-01-31

Family

ID=20055985

Family Applications (1)

Application Number Title Priority Date Filing Date
YU94592A YU48961B (sh) 1991-10-29 1992-10-29 Kompleksne soli hematoporfirina i njegovih derivata i njihova sinteza

Country Status (18)

Country Link
US (1) US5451599A (sh)
EP (1) EP0539960B1 (sh)
JP (1) JP3020759B2 (sh)
CN (1) CN1040328C (sh)
BG (1) BG61648B1 (sh)
CA (1) CA2081605C (sh)
CZ (1) CZ281694B6 (sh)
DE (1) DE69217819T2 (sh)
DK (1) DK0539960T3 (sh)
FI (1) FI100243B (sh)
HR (1) HRP921337B1 (sh)
LV (1) LV11952B (sh)
NO (1) NO300499B1 (sh)
PL (1) PL165249B1 (sh)
RU (1) RU2122003C1 (sh)
SI (1) SI9200286B (sh)
UA (1) UA40568C2 (sh)
YU (1) YU48961B (sh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO180167C (no) 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
US5948771A (en) * 1996-01-31 1999-09-07 The Trustees Of Columbia University In The City Of New York Method for treating heart failure using tetrapyrroles and metallotetrapyrroles
GB9606293D0 (en) * 1996-03-26 1996-05-29 William Harvey Research Limite Treatment of cancers and other tumours
DK1339862T3 (en) 2000-11-29 2014-02-17 Pci Biotech As PHOTO CHEMICAL INTERNALISATION VIRUS-MEDIATED MOLECULAR-DELIVERY INTO cytosol
CZ301427B6 (cs) 2000-11-29 2010-02-24 Pci Biotech As Zpusob zavedení molekuly do cytosolu bunky
CN104130266A (zh) * 2013-05-02 2014-11-05 中国医学科学院生物医学工程研究所 一种新型原卟啉衍生物及制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912M (fr) * 1963-07-24 1964-11-09 Rech S Pharma E R P H A R Soc Dichlorhydrate d'hématoporphyrinate de procaine.
US4849207A (en) * 1985-10-23 1989-07-18 Nihon Medi-Physics Co., Ltd. Porphyrin derivatives
US4882234A (en) * 1986-11-12 1989-11-21 Healux, Inc. Storage-stable porphin compositions and a method for their manufacture
US5190966A (en) * 1988-07-06 1993-03-02 Health Research, Inc. Purified hematoporphyrin dimers and trimers useful in photodynamic therapy
US4968715A (en) * 1988-07-06 1990-11-06 Health Research, Inc. Use of purified hematoporphyrin trimers in photodynamic therapy
US4961920A (en) * 1988-12-08 1990-10-09 Luminis Pty, Ltd. Phototherapeutic monovinyl and divinyl ether-linked dimers
CN102565846B (zh) * 2011-12-30 2014-05-14 清华大学 蜂窝型热中子探测器

Also Published As

Publication number Publication date
CN1071914A (zh) 1993-05-12
EP0539960A2 (en) 1993-05-05
YU48961B (sh) 2003-01-31
SI9200286B (en) 2001-06-30
RU2122003C1 (ru) 1998-11-20
BG97030A (bg) 1994-03-24
NO924151L (no) 1993-04-30
NO924151D0 (no) 1992-10-28
PL292220A1 (en) 1993-09-20
DE69217819T2 (de) 1997-09-04
HRP921337A2 (en) 1994-10-31
JP3020759B2 (ja) 2000-03-15
BG61648B1 (bg) 1998-02-27
CN1040328C (zh) 1998-10-21
FI924856A0 (fi) 1992-10-26
JPH05262775A (ja) 1993-10-12
CZ281694B6 (cs) 1996-12-11
PL165249B1 (pl) 1994-11-30
FI924856A (fi) 1993-04-30
US5451599A (en) 1995-09-19
LV11952A (lv) 1998-01-20
EP0539960A3 (en) 1993-06-16
CA2081605C (en) 2002-02-26
DK0539960T3 (da) 1997-09-15
NO300499B1 (no) 1997-06-09
CA2081605A1 (en) 1993-04-30
UA40568C2 (uk) 2001-08-15
FI100243B (fi) 1997-10-31
HRP921337B1 (en) 2000-02-29
CZ325292A3 (en) 1993-09-15
SI9200286A (en) 1993-06-30
LV11952B (en) 1998-06-20
DE69217819D1 (de) 1997-04-10
EP0539960B1 (en) 1997-03-05

Similar Documents

Publication Publication Date Title
ZA939578B (en) Vinylene azaindole derivatives and process for their preparation
PT79834B (fr) Procede de preparation de nouveaux derives de la xanthine
EP0353955A3 (en) Novel compounds
MX9504381A (es) Derivados de ureido de acidos naftalenfosfonicos y procesos para su preparacion.
ES2014244B3 (es) Nuevo procedimiento de sintesis de (met) acrilamida de n-dialquilaminoalquilo.
SE7906026L (sv) Metafenylendiaminer och fergkompositioner, som innehaller dessa foreningar
NZ240050A (en) Substituted piperazine derivatives; pharmaceutical compositions and preparatory processes
FR2434154A1 (fr) Nouveaux derives d'imidazole, utiles notamment comme anticonvulsivants, et leur procede de preparation
YU94592A (sh) Kompleksne soli hematoporfirina i njegovih derivata i postupak za njihovo dobivanje
ES8403877A1 (es) Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol.
SE7703901L (sv) Polymer
ES8301220A1 (es) Procedimiento para la preparacion de derivados de imidazol
PT76934B (en) Process for the preparation of novel cetene-thio-acetals
ES443912A1 (es) Procedimiento para preparar derivados del acido fenil-aceti-co.
HUT45039A (en) Process for producing new benzhydryl-piperazine derivatives and pharmaceuticals comprising the compounds
FR2435466A1 (fr) Derives de l'hydroquinone et leur procede de preparation
NO873564D0 (no) Nye tyroninderivater.
FR2416214A1 (fr) Derives d'acide naphtyl-1 acetique, leur procede de preparation et leur application therapeutique
NO870077L (no) Nye tyroninderivater.
DE3686185D1 (de) N-substituierte 3,4-dihydropyrimidinderivate, verfahren zu deren herstellung und diese enthaltende zusammenstellung fuer die behandlung von anordnungen eines kardiovascularen systems.
FR2376190A1 (fr) Procede de preparation de pigments azoiques
KR900701752A (ko) 인돌 아세트산 유도체, 그의 제조법 및 이를 유효성분으로 하는 의약
CH612180A5 (en) Process for the preparation of novel pyroglutamyl compounds
JPS567756A (en) Preparation of optically active d-alpha-methyl-beta- mercaptopropionic acid derivative
GB1309714A (en) Propionic acid derivatives and therapeutic compositions containing them